Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage.

Abstract:

:We demonstrated that Flk-1(+) cells derived from mouse embryonic stem (ES) cells can differentiate into both endothelial cells (ECs) and mural cells (MCs) to suffice as vascular progenitor cells (VPCs). In the present study, we investigated the importance of the stage of ES cell differentiation on effective participation in adult neovascularization. We obtained Flk-1(+) LacZ-expressing undifferentiated VPCs. Additional culture of these VPCs with vascular endothelial growth factor (VEGF) resulted in a mixture of ECs and MCs (differentiated VPCs). We injected VPCs subcutaneously into tumor-bearing mice. Five days after the injection, whereas undifferentiated VPCs were often detected as nonvascular cells, differentiated VPCs were more specifically incorporated into developing vasculature mainly as ECs. VPC-derived MCs were also detected in vascular walls. Furthermore, transplantation of differentiated VPCs augmented tumor blood flow in nude mice. These results indicate that a specific vascular contribution in adult neovascularization can be achieved by selective transplantation of ES cell-derived VPCs in appropriate differentiation stages, which should be the basis for vascular regeneration schemes.

journal_name

Blood

journal_title

Blood

authors

Yurugi-Kobayashi T,Itoh H,Yamashita J,Yamahara K,Hirai H,Kobayashi T,Ogawa M,Nishikawa S,Nishikawa S,Nakao K

doi

10.1182/blood-2002-06-1877

subject

Has Abstract

pub_date

2003-04-01 00:00:00

pages

2675-8

issue

7

eissn

0006-4971

issn

1528-0020

pii

2002-06-1877

journal_volume

101

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Role of GM-CSF signaling in cell-based tumor immunization.

    abstract::Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent adjuvant in cancer vaccination; however, the specific role of endogenous GM-CSF remains unknown. We performed cell-based vaccination in 2 tumor models. First, we vaccinated C57BL/6 mice lacking either GM-CSF, IL-5, or beta-common chain (betac), a re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-161075

    authors: Zarei S,Schwenter F,Luy P,Aurrand-Lions M,Morel P,Kopf M,Dranoff G,Mach N

    更新日期:2009-06-25 00:00:00

  • Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha.

    abstract::In a single institution, we have used recombinant interferon- (IFN-) to treat 116 newly diagnosed Philadelphia-positive (Ph+) chronic myeloid leukemia (CML) patients and analyzed the predictive factors for response and survival. The patients whose median age was 50.3 years (range, 9 to 70) were administered IFN- (5 mi...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Mahon FX,Fabères C,Pueyo S,Cony-Makhoul P,Salmi R,Boiron JM,Marit G,Bilhou-Nabera C,Carrère A,Montastruc M,Pigneux A,Bernard P,Reiffers J

    更新日期:1998-12-01 00:00:00

  • Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow.

    abstract::Hematologic engraftment and immune reconstitution were examined in patients who received cyclophosphamide and total body irradiation therapy followed by infusion of autologous bone marrow purged with anti-B1 monoclonal antibody (MoAb) and complement as therapy for non-Hodgkin's lymphoma. Hematologic engraftment was pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Anderson KC,Ritz J,Takvorian T,Coral F,Daley H,Gorgone BC,Freedman AS,Canellos GP,Schlossman SF,Nadler LM

    更新日期:1987-02-01 00:00:00

  • Extracellular histones induce erythrocyte fragility and anemia.

    abstract::Extracellular histones have been shown to play an important pathogenic role in many diseases, primarily through their cytotoxicity toward nucleated cells and their ability to promote platelet activation with resultant thrombosis and thrombocytopenia. In contrast, little is known about the effect of extracellular histo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-790519

    authors: Kordbacheh F,O'Meara CH,Coupland LA,Lelliott PM,Parish CR

    更新日期:2017-12-28 00:00:00

  • Characterization of monoclonal antibodies that recognize canine CD34.

    abstract::Using a polyclonal antiserum against canine CD34, we previously found that CD34 is expressed on canine bone marrow progenitor cells in a manner analogous to that found in humans. To further characterize CD34+ cells and to facilitate preclinical canine stem cell transplant studies, monoclonal antibodies (MoAbs) were ra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McSweeney PA,Rouleau KA,Wallace PM,Bruno B,Andrews RG,Krizanac-Bengez L,Sandmaier BM,Storb R,Wayner E,Nash RA

    更新日期:1998-03-15 00:00:00

  • The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

    abstract::Lymphomas were studied in kindreds with autoimmune lymphoproliferative syndrome (ALPS; Canale-Smith syndrome), a disorder of lymphocyte homeostasis usually associated with germline Fas mutations. Fas (CD95/APO-1) is a cell surface receptor that initiates programmed cell death, or apoptosis, of activated lymphocytes. L...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.1.194

    authors: Straus SE,Jaffe ES,Puck JM,Dale JK,Elkon KB,Rösen-Wolff A,Peters AM,Sneller MC,Hallahan CW,Wang J,Fischer RE,Jackson CE,Lin AY,Bäumler C,Siegert E,Marx A,Vaishnaw AK,Grodzicky T,Fleisher TA,Lenardo MJ

    更新日期:2001-07-01 00:00:00

  • Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses.

    abstract::The human immunodeficiency virus (HIV) causes impairment of the immune system in part by targeting CD4(+) T cells for infection and dysfunction. HIV envelope (Env) present on free virions and infected cells causes dysfunction of uninfected bystander CD4(+) T cells via interaction with both CD4 and coreceptors. Env is ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-038661

    authors: Fernando K,Hu H,Ni H,Hoxie JA,Weissman D

    更新日期:2007-03-15 00:00:00

  • Association of tissue factor pathway inhibitor with human umbilical vein endothelial cells.

    abstract::Tissue factor pathway inhibitor (TFPI) is a serine protease inhibitor of the extrinsic coagulation system, synthesized in endothelial cells, which has recently been shown to play an important role in the regulation of activated coagulation factors at the endothelial cell surface. In the present study we investigated t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hansen JB,Olsen R,Webster P

    更新日期:1997-11-01 00:00:00

  • The transcriptional coactivator Maml1 is required for Notch2-mediated marginal zone B-cell development.

    abstract::Signaling mediated by various Notch receptors and their ligands regulates diverse biological processes, including lymphoid cell fate decisions. Notch1 is required during T-cell development, while Notch2 and the Notch ligand Delta-like1 control marginal zone B (MZB) cell development. We previously determined that Maste...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-097030

    authors: Wu L,Maillard I,Nakamura M,Pear WS,Griffin JD

    更新日期:2007-11-15 00:00:00

  • Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.

    abstract::Inhibition of the tissue factor pathway has been shown to attenuate the activation of coagulation and to prevent death in a gram-negative bacteremia primate model of sepsis. It has been suggested that tissue factor influences inflammatory cascades other than the coagulation system. The authors sought to determine the ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: de Jonge E,Dekkers PE,Creasey AA,Hack CE,Paulson SK,Karim A,Kesecioglu J,Levi M,van Deventer SJ,van Der Poll T

    更新日期:2000-02-15 00:00:00

  • Hemoglobin level is linked to growth hormone-dependent proteins in short children.

    abstract::Erythropoiesis was investigated in 32 children wih short stature and in eight children with skeletal dysplasia by studying blood hemoglobin in relation to growth and to serum concentrations of insulin-like growth factor I (IGF-I), IGF binding protein-3 (IGFBP-3), and erythropoietin (EPO) before, during, and after 12 m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vihervuori E,Virtanen M,Koistinen H,Koistinen R,Seppälä M,Siimes MA

    更新日期:1996-03-01 00:00:00

  • Putative oncogenic role of the erythropoietin receptor in murine and human erythroleukemia cells.

    abstract::To determine whether the erythropoietin receptor (Epo-R) plays a role in the course of malignant erythropoietic disorders, this gene was studied in murine and human erythroleukemia cells. An altered Epo-R gene was found in a murine Friend erythroleukemia cell line, FCL1, due to a spleen focus-forming virus (SFFV) long...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chretien S,Moreau-Gachelin F,Apiou F,Courtois G,Mayeux P,Dutrillaux B,Cartron JP,Gisselbrecht S,Lacombe C

    更新日期:1994-04-01 00:00:00

  • Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines.

    abstract::Nonsteroidal antiinflammatory agents (NSAIA) have been shown to exert potent chemopreventive activity against colon, lung, and breast cancers. In this study, we show that at pharmacological concentrations (1 to 3 mmol/L) sodium salicylate (Na-Sal) can potently induce programmed cell death in several human myeloid leuk...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Klampfer L,Cammenga J,Wisniewski HG,Nimer SD

    更新日期:1999-04-01 00:00:00

  • Fev regulates hematopoietic stem cell development via ERK signaling.

    abstract::Reprogramming of somatic cells to desired cell types holds great promise in regenerative medicine. However, production of transplantable hematopoietic stem cells (HSCs) in vitro by defined factors has not yet been achieved. Therefore, it is critical to fully understand the molecular mechanisms of HSC development in vi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-10-462655

    authors: Wang L,Liu T,Xu L,Gao Y,Wei Y,Duan C,Chen GQ,Lin S,Patient R,Zhang B,Hong D,Liu F

    更新日期:2013-07-18 00:00:00

  • Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.

    abstract::One hundred seventy-nine patients with acute nonlymphoblastic leukemia in first remission (n = 75), chronic myelocytic leukemia in chronic or accelerated phase (n = 48) or leukemia in advanced stage (n = 56) were given HLA-identical marrow grafts and randomized to receive methotrexate or cyclosporine for prevention of...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Storb R,Deeg HJ,Fisher L,Appelbaum F,Buckner CD,Bensinger W,Clift R,Doney K,Irle C,McGuffin R

    更新日期:1988-02-01 00:00:00

  • CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase.

    abstract::CD10/neutral endopeptidase 24.11 (NEP) regulates peptidemediated proliferation of lymphoid progenitors and certain epithelial cells and is itself regulated by cellular proliferation. To further characterize mechanisms by which cell-surface signaling might regulate CD10/NEP expression, we determined whether CD10/NEP wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ganju RK,Shpektor RG,Brenner DG,Shipp MA

    更新日期:1996-12-01 00:00:00

  • Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0).

    abstract::An understanding of mechanisms regulating hematopoietic stem cell engraftment is of pivotal importance to the clinical use of cultured and genetically modified transplants. Human cord blood (CB) cells with lymphomyeloid repopulating activity in NOD/SCID mice were recently shown to undergo multiple self-renewal divisio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Glimm H,Oh IH,Eaves CJ

    更新日期:2000-12-15 00:00:00

  • Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.

    abstract::Src homology 2 domain-containing phosphatase 2 (Shp2), encoded by Ptpn11, is a member of the nonreceptor protein-tyrosine phosphatase family, and functions in cell survival, proliferation, migration, and differentiation in many tissues. Here we report that loss of Ptpn11 in murine hematopoietic cells leads to bone mar...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-319517

    authors: Chan G,Cheung LS,Yang W,Milyavsky M,Sanders AD,Gu S,Hong WX,Liu AX,Wang X,Barbara M,Sharma T,Gavin J,Kutok JL,Iscove NN,Shannon KM,Dick JE,Neel BG,Braun BS

    更新日期:2011-04-21 00:00:00

  • Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant.

    abstract::Activated protein C (APC) reduces mortality in severe sepsis patients. APC exerts anticoagulant activities via inactivation of factors Va and VIIIa and cytoprotective activities via endothelial protein C receptor and protease-activated receptor-1. APC mutants with selectively altered and opposite activity profiles, th...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-183327

    authors: Mosnier LO,Zampolli A,Kerschen EJ,Schuepbach RA,Banerjee Y,Fernández JA,Yang XV,Riewald M,Weiler H,Ruggeri ZM,Griffin JH

    更新日期:2009-06-04 00:00:00

  • Treatment of non-obese diabetic (NOD)/Severe-combined immunodeficient mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells.

    abstract::Until recently, the identification of cellular factors that govern the developmental program of human stem cells has been difficult due to the absence of repopulation assays that detect human stem cells. The transplantation of human bone marrow (BM) or cord blood (CB) into non-obese diabetic (NOD)/severe-combined immu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kapp U,Bhatia M,Bonnet D,Murdoch B,Dick JE

    更新日期:1998-09-15 00:00:00

  • BCR-ABL point mutants isolated from patients with imatinib mesylate-resistant chronic myeloid leukemia remain sensitive to inhibitors of the BCR-ABL chaperone heat shock protein 90.

    abstract::Clinical resistance to imatinib mesylate is commonly observed in patients with advanced Philadelphia chromosome- positive (Ph(+)) leukemias. Acquired resistance is typically associated with reactivation of BCR-ABL due to kinase domain mutations or gene amplification, indicating that BCR-ABL remains a viable target for...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1361

    authors: Gorre ME,Ellwood-Yen K,Chiosis G,Rosen N,Sawyers CL

    更新日期:2002-10-15 00:00:00

  • Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia.

    abstract::The capacity to convert exogenous leukotriene A4 to lipoxins (LXs) was investigated in platelet suspensions from patients with myeloproliferative disorders (MPD) (n = 22) and healthy control subjects (n = 14). Platelets isolated from the controls produced mainly LXA4, but also 6(S)-LXA4 and the all-trans isomers of li...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Stenke L,Edenius C,Samuelsson J,Lindgren JA

    更新日期:1991-12-01 00:00:00

  • Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.

    abstract::The effect of donor/recipient histocompatibility on relapse in patients receiving T-cell-depleted (TCD) grafts for chronic myelogenous leukemia (CML) was evaluated. Specifically, we sought to determine whether TCD results in an attenuation of the graft-versus-leukemia (GVL) effect on recipients of unrelated marrow gra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hessner MJ,Endean DJ,Casper JT,Horowitz MM,Keever-Taylor CA,Roth M,Flomenberg N,Drobyski WR

    更新日期:1995-11-15 00:00:00

  • GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment.

    abstract::Recent studies have established that during embryonic development, hematopoietic progenitors and stem cells are generated from hemogenic endothelium precursors through a process termed endothelial to hematopoietic transition (EHT). The transcription factor RUNX1 is essential for this process, but its main downstream e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-10-386094

    authors: Lancrin C,Mazan M,Stefanska M,Patel R,Lichtinger M,Costa G,Vargel O,Wilson NK,Möröy T,Bonifer C,Göttgens B,Kouskoff V,Lacaud G

    更新日期:2012-07-12 00:00:00

  • A case of mistaken identity.

    abstract::McCullough and colleagues show that problems with cord banking still exist. To improve the results of cord transplantations, more attention should be given to ensuring quality standards rather than just collecting more units. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2009-06-226738

    authors: Querol S

    更新日期:2009-08-20 00:00:00

  • In vivo generation of human dendritic cell subsets by Flt3 ligand.

    abstract::Dendritic cells (DCs) represent a family of ontogenically distinct leukocytes involved in immune response regulation. The ability of DCs to stimulate T-cell immunity has led to their use as vectors for immunotherapy vaccines. However, it is unclear whether and to what degree in vitro-generated DCs are representative o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Maraskovsky E,Daro E,Roux E,Teepe M,Maliszewski CR,Hoek J,Caron D,Lebsack ME,McKenna HJ

    更新日期:2000-08-01 00:00:00

  • Stimulation of neutrophil oxidative metabolism by the alternate pathway of complement activation: a mechanism for the spontaneous NBT test.

    abstract::The reduction of nitroblue tetrazolium dye by human neutrophils was measured in the presence of serum in which the complement system had been activated through the alternate pathway by interaction with inulin. Neutrophils incubated with serum inulin supernatants reduced the dye and showed a general increase in oxidati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Strauss RG,Mauer AM,Asbrock T,Spitzer RE,Stitzel AE

    更新日期:1975-06-01 00:00:00

  • Characterization of nuclear factors that bind to a critical positive regulatory element of the human granulocyte-macrophage colony-stimulating factor promoter.

    abstract::Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor that stimulates the proliferation, maturation, and functional activity of myeloid cells in peripheral blood and bone marrow. Expression of GM-CSF is tightly regulated and is limited to cells stimulated directly (T cells, macroph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fraser JK,Tran S,Nimer SD,Gasson JC

    更新日期:1994-10-15 00:00:00

  • Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives.

    abstract::Thrombophilia screening is controversial. In a retrospective family cohort, where probands had thrombosis and a thrombophilic defect, 2479 relatives were tested for thrombophilia. In antithrombin-, protein C-, and protein S-deficient relatives, annual incidences of venous thrombosis were 1.77% (95% CI, 1.14-2.60), 1.5...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-184879

    authors: Lijfering WM,Brouwer JL,Veeger NJ,Bank I,Coppens M,Middeldorp S,Hamulyák K,Prins MH,Büller HR,van der Meer J

    更新日期:2009-05-21 00:00:00

  • Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia.

    abstract::Derivative chromosome 9 deletions are seen in 10% to 15% of patients with chronic myelogenous leukemia and have been associated with a poor prognosis; however, no studies have been performed in the context of a randomized clinical trial. We developed a DNA-based deletion screen and investigated 339 chronic phase patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-02-074252

    authors: Kreil S,Pfirrmann M,Haferlach C,Waghorn K,Chase A,Hehlmann R,Reiter A,Hochhaus A,Cross NC,German Chronic Myelogenous Leukemia (CML) Study Group.

    更新日期:2007-08-15 00:00:00